Literature DB >> 9199420

Intrapulmonary response to Histoplasma capsulatum in gamma interferon knockout mice.

R Allendoerfer1, G S Deepe.   

Abstract

We examined the immunobiological responses to Histoplasma capsulatum in lungs of gamma interferon (IFN-gamma) knockout mice (GKO mice). Naive GKO mice succumbed by day 9 to intranasal challenge with 2.5 x 10(6) yeasts, whereas all wild-type (WT) mice survived for 45 days. Compared to lungs of WT mice, the lungs of acutely infected GKO mice exhibited dramatically elevated numbers of CFU in lungs and significantly higher levels of tumor necrosis factor alpha (TNF-alpha) and granulocyte-macrophage colony-stimulating factor (GM-CSF) but not interleukin-12 (IL-12) or IL-4. To determine if IFN-gamma is necessary in reexposure histoplasmosis, GKO and WT mice were inoculated with 10(4) yeasts intranasally and given amphotericin B for 3 weeks. Six weeks later, mice were rechallenged with 2.5 x 10(6) yeasts. All GKO mice died by day 6, whereas all WT mice survived for 45 days. Lungs of GKO mice contained substantially elevated numbers of CFU and higher TNF-alpha and GM-CSF levels but not IL-12 or IL-4. Thus, IFN-gamma is requisite for control of pulmonary histoplasmosis in naive and reexposed mice.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9199420      PMCID: PMC175362          DOI: 10.1128/iai.65.7.2564-2569.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  The role of IFN-gamma in delayed-type hypersensitivity mediated by Th1 clones.

Authors:  T A Fong; T R Mosmann
Journal:  J Immunol       Date:  1989-11-01       Impact factor: 5.422

Review 2.  Histoplasmosis and AIDS.

Authors:  J R Graybill
Journal:  J Infect Dis       Date:  1988-09       Impact factor: 5.226

3.  Role of L3T4+ T cells in host defense against Histoplasma capsulatum.

Authors:  A M Gomez; W E Bullock; C L Taylor; G S Deepe
Journal:  Infect Immun       Date:  1988-07       Impact factor: 3.441

4.  Amphotericin B induces tumor necrosis factor production by murine macrophages.

Authors:  J K Chia; M Pollack
Journal:  J Infect Dis       Date:  1989-01       Impact factor: 5.226

5.  Relative susceptibilities of inbred mouse strains C57BL/6 and A/J to infection with Histoplasma capsulatum.

Authors:  B Wu-Hsieh
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

6.  Modulation of immune responses in murine pulmonary histoplasmosis.

Authors:  R Allendoerfer; G P Biovin; G S Deepe
Journal:  J Infect Dis       Date:  1997-04       Impact factor: 5.226

7.  Effects of amphotericin B on macrophages and their precursor cells.

Authors:  S H Lin; G Medoff; G S Kobayashi
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

8.  IL-12 prevents mortality in mice infected with Histoplasma capsulatum through induction of IFN-gamma.

Authors:  P Zhou; M C Sieve; J Bennett; K J Kwon-Chung; R P Tewari; R T Gazzinelli; A Sher; R A Seder
Journal:  J Immunol       Date:  1995-07-15       Impact factor: 5.422

9.  Secondary response to Listeria infection requires IFN-gamma but is partially independent of IL-12.

Authors:  C S Tripp; O Kanagawa; E R Unanue
Journal:  J Immunol       Date:  1995-10-01       Impact factor: 5.422

10.  Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.

Authors:  C A Dinarello; J G Cannon; S M Wolff; H A Bernheim; B Beutler; A Cerami; I S Figari; M A Palladino; J V O'Connor
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

View more
  58 in total

1.  Apoptosis modulates protective immunity to the pathogenic fungus Histoplasma capsulatum.

Authors:  Holly L Allen; George S Deepe
Journal:  J Clin Invest       Date:  2005-09-08       Impact factor: 14.808

2.  Interleukin-1 and host control of pulmonary histoplasmosis.

Authors:  George S Deepe; Michael McGuinness
Journal:  J Infect Dis       Date:  2006-08-10       Impact factor: 5.226

3.  Pulmonary V beta 4+ T cells from Histoplasma capsulatum-infected mice respond to a homologue of Sec31 that confers a protective response.

Authors:  Mark R Scheckelhoff; George S Deepe
Journal:  J Infect Dis       Date:  2006-02-09       Impact factor: 5.226

Review 4.  Dendritic cell interactions with Histoplasma and Paracoccidioides.

Authors:  Sharanjeet K Thind; Carlos P Taborda; Joshua D Nosanchuk
Journal:  Virulence       Date:  2015-05-01       Impact factor: 5.882

5.  Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice.

Authors:  P Connolly; L J Wheat; C Schnizlein-Bick; M Durkin; S Kohler; M Smedema; J Goldberg; E Brizendine; D Loebenberg
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

6.  MyD88-dependent signaling drives host survival and early cytokine production during Histoplasma capsulatum infection.

Authors:  Alison Coady; Anita Sil
Journal:  Infect Immun       Date:  2015-01-12       Impact factor: 3.441

Review 7.  Flying under the radar: Histoplasma capsulatum avoidance of innate immune recognition.

Authors:  Stephanie C Ray; Chad A Rappleye
Journal:  Semin Cell Dev Biol       Date:  2018-03-21       Impact factor: 7.727

8.  Expression of hygromycin phosphotransferase alters virulence of Histoplasma capsulatum.

Authors:  A George Smulian; Reta S Gibbons; Jeffery A Demland; Deborah T Spaulding; George S Deepe
Journal:  Eukaryot Cell       Date:  2007-09-14

9.  Blockade of endogenous leukotrienes exacerbates pulmonary histoplasmosis.

Authors:  Alexandra I Medeiros; Anderson Sá-Nunes; Edson G Soares; Camila M Peres; Célio L Silva; Lúcia H Faccioli
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

10.  Histoplasma capsulatum proteome response to decreased iron availability.

Authors:  Michael S Winters; Daniel S Spellman; Qilin Chan; Francisco J Gomez; Margarita Hernandez; Brittany Catron; Alan G Smulian; Thomas A Neubert; George S Deepe
Journal:  Proteome Sci       Date:  2008-12-24       Impact factor: 2.480

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.